Antiretroviral Therapy (ART) and the Central Nervous System (CNS)
With the introduction of combination antiretroviral therapy (CART), also known as highly active antiretroviral therapy (HAART), for the control of human immunodeficiency virus (HIV) infection, it has been possible to suppress viral quantity in patients’ blood, often to undetectable levels. This intervention has decreased the overall HIV/AIDS disease burden and increased the life span of HIV-infected individuals. However, HIV reservoirs persist in tissue compartments where there is limited access of antiretroviral drugs and/or the presence of long-lived latent HIV reservoirs. Given these circumstances, the complete control of HIV replication and the eradication of HIV have been difficult and infected individuals must continue on treatment regimens indefinitely. Antiretroviral therapies (ARTs) are essential for the effective treatment of HIV infection, but these compounds also have intrinsic toxicity and with long-term...
This is a preview of subscription content, log in via an institution.
References
Akay C, Cooper M, Odeleye A, Jensen BK, White MG, et al. Antiretroviral drugs induce oxidative stress and neuronal damage in the central nervous system. J Neurovirol. 2014;20:39–53.
Ciccarelli N, Fabbiani M, Di Giambenedetto S, Fanti I, Baldonero E, et al. Efavirenz associated with cognitive disorders in otherwise asymptomatic HIV-infected patients. Neurology. 2011;76:1403–9.
Cysique LA, Brew BJ. Neuropsychological functioning and antiretroviral treatment in HIV/AIDS: a review. Neuropsychol Rev. 2009;19:169–85.
Evans SR, Ellis RJ, Chen H, Yeh TM, Lee AJ, et al. Peripheral neuropathy in HIV: prevalence and risk factors. AIDS. 2011;25:919–28.
Foster R, Olajide D, Everall IP. Antiretroviral therapy-induced psychosis: case report and brief review of the literature. HIV Med. 2003;4:139–44.
Giunta B, Ehrhart J, Obregon DF, Lam L, Le L, et al. Antiretroviral medications disrupt microglial phagocytosis of beta-amyloid and increase its production by neurons: implications for HIV-associated neurocognitive disorders. Mol Brain. 2011;4:23.
Heaton RK, Franklin DR, Ellis RJ, McCutchan JA, Letendre SL, et al. HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors. J Neurovirol. 2011;17:3–16.
Koczor CA, Lewis W. Nucleoside reverse transcriptase inhibitor toxicity and mitochondrial DNA. Expert Opin Drug Metab Toxicol. 2010;6:1493–504.
Leeansyah E, Cameron PU, Solomon A, Tennakoon S, Velayudham P, et al. Inhibition of telomerase activity by human immunodeficiency virus (HIV) nucleos(t)ide reverse transcriptase inhibitors: a potential factor contributing to HIV-associated accelerated aging. J Infect Dis. 2013;207:1157–65.
Reust CE. Common adverse effects of antiretroviral therapy for HIV disease. Am Fam Physician. 2011;83:1443–51.
Robertson KR, Su Z, Margolis DM, Krambrink A, Havlir DV, et al. Neurocognitive effects of treatment interruption in stable HIV-positive patients in an observational cohort. Neurology. 2010;74:1260–6.
Robertson K, Liner J, Meeker RB. Antiretroviral neurotoxicity. J Neurovirol. 2012;18:388–99.
Schweinsburg BC, Taylor MJ, Alhassoon OM, Gonzalez R, Brown GG, et al. Brain mitochondrial injury in human immunodeficiency virus-seropositive (HIV+) individuals taking nucleoside reverse transcriptase inhibitors. J Neurovirol. 2005;11:356–64.
Thompson MA, Aberg JA, Hoy JF, Telenti A, Benson C, et al. Antiretroviral treatment of adult HIV infection: 2012 recommendations of the International Antiviral Society-USA panel. JAMA. 2012;308:387–402.
Tovar-y-Romo LB, Bumpus NN, Pomerantz D, Avery LB, Sacktor N, et al. Dendritic spine injury induced by the 8-hydroxy metabolite of efavirenz. J Pharmacol Exp Ther. 2012;343:696–703.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this entry
Cite this entry
Meeker, R.B., Robertson, K., Power, C. (2014). Neurotoxic Consequences of Antiretroviral Therapies. In: Hope, T., Stevenson, M., Richman, D. (eds) Encyclopedia of AIDS. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-9610-6_223-1
Download citation
DOI: https://doi.org/10.1007/978-1-4614-9610-6_223-1
Received:
Accepted:
Published:
Publisher Name: Springer, New York, NY
Online ISBN: 978-1-4614-9610-6
eBook Packages: Springer Reference MedicineReference Module Medicine